title: Decrease in acetylcholine-induced current by neomycin in PC12 cells.
abstract: The effects of neomycin, one of the aminoglycoside antibiotics, on the acetylcholine (ACh)-induced current (I(ACh)) were studied in pheochromocytoma cells by using the whole-cell clamp technique. The I(ACh) proved to be generated through neuronal nicotinic receptor. ACh (30 microM) induced an inward current at a holding potential of -80 mV. When cells were treated with neomycin (0.01-1 mM) and ACh (30 microM) simultaneously, an inhibitory effect of neomycin on the peak of I(ACh) was found. This effect was fast, reversible, and concentration dependent. Pretreatment with neomycin for 3-8 min had no effect on the inhibition of I(ACh) induced by neomycin. External application of 0.1 mM neomycin neither shifted the dose-response curve of the peak I(ACh) to the right (dissociation constant (K(d)) = 16.5 microM) nor affected its coefficient (1.8) but inhibited the curve amplitudes by approximately 33%. Stimulated protein kinase C activation by using an exogenous activator produced inhibition of I(ACh), while using protein kinase C inhibitor (PKCI 19-31) had no effect on the inhibition of I(ACh) induced by neomycin. These results suggest that neomycin has an inhibitory effect on I(ACh) without the involvement of phospholipase C. It indicates that neomycin binds to a specific site on the cell membrane, probably on the neuronal nicotinic receptor-coupled channel, and inhibits the I(ACh) in a noncompetitive manner, thus controlling the immediate catecholamine release from the sympathetic cells.
authors.affiliation: Department of Physiology, Beijing Medical College of PLA, Beijing 100071, China. l.j.shi@263.net
authors.forename: Li-jun
authors.initials: LJ
authors.lastname: Shi
authors.forename: Ling-ai
authors.initials: LA
authors.lastname: Liu
authors.forename: Xiao-hong
authors.initials: XH
authors.lastname: Cheng
authors.forename: Chun-an
authors.initials: CA
authors.lastname: Wang
mesh_terms: D000109:Acetylcholine / Q000378:metabolism* / Q000494:pharmacology*; D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001665:Binding Sites; D001667:Binding, Competitive; D002273:Carcinogens; D004305:Dose-Response Relationship, Drug; D004594:Electrophysiology; D020128:Inhibitory Concentration 50; D009355:Neomycin / Q000494:pharmacology*; D016716:PC12 Cells; D051381:Rats; D013755:Tetradecanoylphorbol Acetate; D013997:Time Factors; D010738:Type C Phospholipases / Q000378:metabolism
chemical_list: D000900:Anti-Bacterial Agents; D002273:Carcinogens; D010738:Type C Phospholipases; D009355:Neomycin; D000109:Acetylcholine; D013755:Tetradecanoylphorbol Acetate